Bacteremia in Lung Transplant Recipients in the Current Era
暂无分享,去创建一个
A. Humar | M. Wagener | S. Palmer | N. Singh | S. Husain | D. Hadjiliadis | K. Chan | K. McCurry
[1] D. Paterson,et al. Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion. , 2006, The Journal of infection.
[2] E. Bouza,et al. Bloodstream Infections among Heart Transplant Recipients , 2006, Transplantation.
[3] J. Trotter,et al. Immunosuppression: Evolution in Practice and Trends, 1994–2004 , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] S. Palmer,et al. Acute Renal Failure after Lung Transplantation: Incidence, Predictors and Impact on Perioperative Morbidity and Mortality , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] Philip F Halloran,et al. Immunosuppressive drugs for kidney transplantation. , 2004, The New England journal of medicine.
[6] D. Snydman,et al. The clinical impact of ganciclovir prophylaxis on the occurrence of bacteremia in orthotopic liver transplant recipients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] L. Danziger-Isakov. Epidemiology of Bloodstream Infections in The First Year After Pediatric Lung Transplantation. , 2004, Pediatric Research.
[8] R. Kotloff,et al. Medical complications of lung transplantation , 2004, European Respiratory Journal.
[9] J. Garnacho-Montero,et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis* , 2003, Critical care medicine.
[10] D. Snydman,et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Nina Singh,et al. Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients. , 2003, The Lancet. Infectious diseases.
[12] A. Mehta,et al. Respiratory failure and sepsis are the major causes of ICU admissions and mortality in survivors of lung transplants. , 2003, Chest.
[13] A. Matas,et al. Predictors of renal function following lung or heart-lung transplantation. , 2002, Kidney international.
[14] T. Fears,et al. Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution. , 2001, European journal of cancer.
[15] I. Marino,et al. Evolving trends in multiple‐antibiotic–resistant bacteria in liver transplant recipients: A longitudinal study of antimicrobial susceptibility patterns , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[16] B. Alexander,et al. Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. , 2000, Transplantation.
[17] Nina Singh,et al. Predicting bacteremia and bacteremic mortality in liver transplant recipients , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[18] G Sherman,et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. , 1999, Chest.
[19] C Brennen,et al. Multiply Antibiotic Resistant Gram-Negative Bacilli in a Long Term Care Facility A Case Control Study of Patient rick Factors and Prior Antibiotic Use , 1997, Infection Control & Hospital Epidemiology.
[20] H. Oz,et al. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone. , 1997, The Journal of infectious diseases.
[21] E. De Clercq,et al. Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections. , 1996, Antiviral research.
[22] J. Donnelly. Bacterial complications of transplantation: diagnosis and treatment. , 1995, The Journal of antimicrobial chemotherapy.
[23] N. Rolando,et al. Bacterial and fungal infections after liver transplantation: An analysis of 284 patients , 1995, Hepatology.
[24] N. Kneteman,et al. Comparative Risk of Bloodstream Infection in Organ Transplant Recipients , 1994, Infection Control & Hospital Epidemiology.
[25] B. Griffith,et al. A decade of lung transplantation. , 1993, Annals of surgery.
[26] B. Yangco,et al. CDC definitions for nosocomial infections. , 1989, American journal of infection control.
[27] J M Hughes,et al. CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.